Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction MEPFL Followed by CCRT in Stage IV NPC
NCT00201396Phase 3Completed
- Sponsor
- National Health Research Institutes
- Start
- Aug 2003
- Primary completion
- Aug 2009
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mitomycin c, epirubicin, cisplatin, fluorouracil, folinic acid in nasopharyngeal carcinoma (NPC), sponsored by National Health Research Institutes. Started Aug 2003; status: completed.
02
Drugs
mitomycin cepirubicincisplatinfluorouracilfolinic acid
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00201396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201396.